Publications by authors named "Elizabeth Kepl"

Claim this Profile
N
Nanoparticles displaying fHbp elicit an enhanced antibody response against meningococcal B isolates compared to low valency fHbp antigens.
Julia L McKechnie, Elizabeth Kepl, Jennifer Louth, Christina J Sun, Jay Lucidarme

Vaccine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens.
Marcos C Miranda, Elizabeth Kepl, Mary Jane Navarro, Chengbo Chen, Max Johnson

NPJ Vaccines· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and immunological evaluation of two-component protein nanoparticle vaccines for East Coast fever.
Anna Lacasta, Hyung Chan Kim, Elizabeth Kepl, Rachael Gachogo, Naomi Chege

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine.
Prabhu S Arunachalam, Yupeng Feng, Usama Ashraf, Mengyun Hu, Alexandra C Walls, Elizabeth Kepl

Sci Transl Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice.
Alexandra C Walls, Laura A VanBlargan, Kai Wu, Angela Choi, Mary Jane Navarro, Elizabeth Kepl

Cell Rep· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein.
M Alejandra Tortorici, Alexandra C Walls, Anshu Joshi, Young-Jun Park, Rachel T Eguia, Elizabeth Kepl

Cell· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice.
Lilit Grigoryan, Audrey Lee, Alexandra C Walls, Lilin Lai, Benjamin Franco, Elizabeth Kepl

NPJ Vaccines· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.
Sasha E Larsen, Bryan J Berube, Tiffany Pecor, Evan Cross, Bryan P Brown, Elizabeth Kepl

J Immunol Methods· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
Alexandra C Walls, Marcos C Miranda, Alexandra Schäfer, Minh N Pham, Allison Greaney, Elizabeth Kepl

Cell· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.
Sasha E Larsen, Bryan J Berube, Tiffany Pecor, Evan Cross, Bryan P Brown, Elizabeth Kepl

bioRxiv· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.
Daniel Ellis, Natalie Brunette, Katharine H D Crawford, Alexandra C Walls, Minh N Pham, Elizabeth Kepl

Front Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.
Prabhu S Arunachalam, Alexandra C Walls, Nadia Golden, Caroline Atyeo, Stephanie Fischinger, Elizabeth Kepl

Nature· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
Alexandra C Walls, Marcos C Miranda, Minh N Pham, Alexandra Schäfer, Allison Greaney, Elizabeth Kepl

bioRxiv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates.
Prabhu S Arunachalam, Alexandra C Walls, Nadia Golden, Caroline Atyeo, Stephanie Fischinger, Elizabeth Kepl

bioRxiv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, Samuel Wrenn, Minh N Pham, Elizabeth Kepl

Cell· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2.
Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, Samuel Wrenn, Minh N Pham, Elizabeth Kepl

bioRxiv· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis